In addition, RA was shown to inhibit MAPK phosphorylation and activate the NF-κB signaling pathway, effectively delaying airway inflammation and providing a potential therapeutic option for the treatment of allergic asthma [16]. Here, NFKB1 is linked to allergic asthma.